Catalyst Tracker

05/01/2024 04:45 PM ET

FibroBiologics FDMT date announcement

4D Molecular Therapeutics already had eight catalyst announcements coming up, but they added another one today. It will be announcing top-line results for their recent Phase 1/2 trial for 4D-150 - (PRISM) on September 30, [...]

05/01/2024 04:45 PM ET

KalVista Pharmaceuticals KALV results announcement

KalVista Pharmaceuticals provided an update to their Phase 1 trial for Sebetralstat - (KONFIDENT-KID). The results were summarized as follows:

"Trial planned for 3Q 2024."

KalVista Pharmaceuticals rocketed up $0.83 (+7.31%) to $12.18 on light [...]

05/01/2024 04:45 PM ET

Minerva Neurosciences NERV earnings announcement

Minerva Neurosciences revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was reported to be -$1.13, which beat the estimated value of -$1.20. Minerva Neurosciences' EPS [...]

05/01/2024 04:45 PM ET

BioAtla SMMT earnings announcement

Summit Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.06. It is now above its average of -$0.32 over the past year.

Investors were clearly happy with [...]

05/01/2024 04:45 PM ET

FibroBiologics TGTX earnings announcement

TG Therapeutics exceeded their revenue estimate but fell short of their EPS estimate, according to their recent quarterly earnings data. Revenue was reported to be $63.47M and EPS was -$0.07. TG Therapeutics' [...]

05/01/2024 04:45 PM ET

Chimerix CMRX earnings announcement

Chimerix revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. Revenue, at $0.00, was the biggest surprise for the quarter, as it missed [...]

05/01/2024 04:45 PM ET

United Therapeutics Corporation UTHR earnings announcement

United Therapeutics Corporation revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. The revenue estimate was $623.97M, but the actual figure was $677.7M. United Therapeutics [...]

05/01/2024 04:45 PM ET

BioAtla GTHX earnings announcement

G1 Therapeutics fell in line with their EPS estimate but fell short of their revenue estimate, according to their recent quarterly earnings data. EPS was -$0.20, exceeding estimates by 4.76%. For [...]

05/01/2024 04:45 PM ET

MiMedx Group MDXG earnings announcement

MiMedx Group revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. EPS was estimated to be $0.04 and the actual figure came in at $0.07. [...]

05/01/2024 04:45 PM ET

FibroBiologics LYRA earnings announcement

Lyra Therapeutics exceeded their revenue estimate but fell short of their EPS estimate, according to their recent quarterly earnings data. The revenue estimate was $420k, but the actual figure was $532k. Lyra [...]

05/01/2024 04:45 PM ET

Exelixis EXEL earnings announcement

Exelixis revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. EPS, at $0.17, was the biggest surprise for the quarter, as it missed [...]

04/30/2024 04:45 PM ET

ALX Oncology Holdings ALXO results announcement

ALX Oncology Holdings has provided investors an update on their recent Phase 2 trial for Evorpacept in combination KEYTRUDA (pembrolizumab) - (IST trial). Our analysts provided the following summary:

"Phase 2 trial initiated April 30, [...]